SVANOVIR®F.hepatica-Ab

12th December 2012

New bovine test kit contributes to reducing the economic losses from Fasciola hepatica infections

The Swedish veterinary diagnostic company, Boehringer Ingelheim Svanova now presents a new ELISA test kit. The kit will help farmers and veterinarians to gain further insights into Fasciola hepatica and the parasite’s impact on production results. This new knowledge will ultimatively ensure better control and more effective management of fascioliasis in cattle farming.

The liver fluke Fasciola hepatica is a common parasite affecting animals as well as humans throughout the world.

In cattle, fascioliasis is generally considered a subclinical disease. Studies have shown that subclinical infections can lead to severe and progressive production losses in cattle farming.

In infected animals we often see liver condemnations at slaughter but also issues such as lower weight gains, reduced milk production and reduced fertility which results in economic losses for the farmer" explains Dr. Johannes Charlier from Ghent University.

 

New test kit returns control to the farmer

Boehringer Ingelheim Svanova now brings a new test to market; a test that will allow farmers to gain more control over the Fasciola hepatica parasite.

With the SVANOVIR®F.hepatica-Ab ELISA test kit, herds and individual animals that exceed an acceptable level of infection can be identified. The test results from the veterinary labs trigger the implementation of control measures in the farm.

Monitoring and controlling herd infection to an acceptable level with no loss of production is a new way to manage fascioliasis. The SVANOVIR®F.hepatica-Ab is a great tool that provides hard facts for optimizing pasture management and treatment strategies which are the two most commonly used control measures” concludes Dr. Johannes Charlier from the University in Ghent.